Revenue has been negligible at $193.5K in 2025 Q1 and Q2 versus $20.5K in 2023 Q3 and Q4, while cost of goods sold of $927.5K produced a gross margin of -3.8%, indicating BRNX is selling below direct production cost.
BrenX Ltd. (BRNX) annual income statement — 11-year revenue, gross profit & net income history
| Metric | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 |
|---|
| Sales/Revenue | 387K | 0 | 621K | 1.52M | 395K | 0 | 92.9K | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | -100% | -59.14% | 284.81% | - | -100% | - | - | - | - | - |
| Cost of Goods Sold | 3.6M | 985K | 1.55M | 2.31M | 4.05M | 122K | 643.84K | 84.56K | 105.64K | 0 | 0 |
| COGS % of Revenue | 929.2% | - | 250.4% | 151.71% | 1025.57% | - | 693.05% | - | - | - | - |
| Gross Profit | -3.21M | -985K | -934K | -786K | -3.66M | -122K | -550.94K | -84.56K | -105.64K | 0 | 0 |
| Gross Margin % | -829.2% | - | -150.4% | -51.71% | -925.57% | - | -593.05% | - | - | - | - |
| Gross Profit Growth % | -225.79% | -5.46% | -18.83% | 78.5% | -2896.72% | 77.86% | -551.57% | 19.96% | - | - | - |
| Operating Expenses | 9.53M | 9.58M | 8.93M | 11.31M | 7.18M | 9.21M | 4.21M | 6.38M | 4.69M | 3.96M | 5.11M |
| OpEx % of Revenue | 2462.27% | - | 1437.36% | 744.28% | 1817.47% | - | 4530.21% | - | - | - | - |
| Selling, General & Admin | 5.21M | 5.13M | 5.03M | 5.69M | 3M | 1.57M | 2.24M | 3.15M | 2.02M | 1.46M | 1.71M |
| SG&A % of Revenue | 1347.03% | - | 809.18% | 374.14% | 758.99% | - | 2408.16% | - | - | - | - |
| Research & Development | 3.96M | 3.59M | 3.17M | 4.97M | 3.7M | 3.91M | 1.97M | 3.23M | 2.67M | 3.22M | 4.31M |
| R&D % of Revenue | 1023.26% | - | 509.82% | 326.97% | 936.71% | - | 2122.06% | - | - | - | - |
| Other Operating Expenses | 356K | 858K | 735K | 656K | 481K | 3.73M | 0 | 0 | 0 | 0 | - |
| Operating Income | -12.74M | -10.56M | -9.86M | -12.1M | -11.96M | -9.33M | -4.76M | -6.46M | -4.8M | -3.96M | -5.11M |
| Operating Margin % | -3291.47% | - | -1587.76% | -795.99% | -3026.58% | - | -5123.26% | - | - | - | - |
| Operating Income Growth % | -20.6% | -7.12% | 18.51% | -1.2% | -28.13% | -96.03% | 26.38% | -34.75% | -21.15% | - | - |
| EBITDA | -12.18M | -10.33M | -9.74M | -11.86M | -11.71M | -8.65M | -4.12M | -6.38M | -4.69M | -3.79M | -4.78M |
| EBITDA Margin % | -3146.51% | - | -1568.44% | -780.26% | -2963.29% | - | -4433.53% | - | - | - | - |
| EBITDA Growth % | -17.83% | -6.1% | 17.88% | -1.32% | -35.29% | -110.07% | 35.44% | -35.99% | -23.83% | - | - |
| D&A (Non-Cash Add-back) | 561K | 228K | 120K | 239K | 250K | 678K | 640.75K | 84.56K | 105.64K | 170.78K | 324.39K |
| EBIT | -13.53M | -6.53M | -9.55M | -11.42M | -10.08M | -9.1M | -11.7M | -6.88M | -4.77M | -3.96M | -5.11M |
| Net Interest Income | -299K | -29K | 49K | -58K | -266K | -371.62K | -504.07K | 0 | 0 | 0 | 0 |
| Interest Income | 75K | 215K | 161K | 51K | 3K | 0 | 842 | 802 | 3.69M | 5.43M | 4.64M |
| Interest Expense | 374K | 244K | 112K | 109K | 269K | 372K | 504.91K | 0 | 0 | 0 | - |
| Other Income/Expense | -1.17M | 3.79M | 212K | 1.03M | -145K | -144.76K | -7.39M | -726.51K | -3.59M | -5.43M | - |
| Pretax Income | -13.9M | -6.77M | -9.65M | -11.07M | -11.02M | -9.47M | -12.15M | -7.19M | -8.39M | -9.39M | -9.75M |
| Pretax Margin % | -3593.02% | - | -1553.62% | -728.09% | -2789.11% | - | -13081.88% | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 25K | 0 | 0 | 0 | 1.67K | -4 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | -0.23% | 0% | 0% | 0% | -0.02% | 0% | 0% | 0% |
| Net Income | -13.9M | -6.77M | -9.65M | -11.07M | -11.02M | -9.48M | -12.15M | -7.19M | -8.39M | -9.39M | -9.75M |
| Net Margin % | -3593.02% | - | -1553.62% | -728.09% | -2789.11% | - | -13081.88% | - | - | - | - |
| Net Income Growth % | -105.33% | 29.81% | 12.82% | -0.45% | -16.2% | 21.99% | -68.96% | 14.25% | 10.62% | - | - |
| Net Income (Continuing) | -13.9M | -6.77M | -9.65M | -11.09M | -11.02M | -9.47M | -12.15M | -7.19M | -8.39M | -9.39M | -9.75M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -57.14 | -45.15 | -174.65 | -264.95 | -59.85 | -41.65 | -56.35 | -39.20 | -58.10 | -730.10 | -758.45 |
| EPS Growth % | -26.56% | 74.15% | 34.08% | -342.69% | -43.7% | 26.09% | -43.75% | 32.53% | 92.04% | - | - |
| EPS (Basic) | -57.14 | -45.15 | -174.65 | -264.95 | -60.55 | -41.65 | -56.35 | -39.20 | -58.10 | -730.10 | -758.45 |
| Diluted Shares Outstanding | 408.79K | 149.59K | 55.77K | 41.79K | 173.13K | 227.15K | 215.94K | 182.97K | 144.15K | 12.86K | 12.86K |
| Basic Shares Outstanding | 408.79K | 149.59K | 55.77K | 41.79K | 170.49K | 227.15K | 215.94K | 182.97K | 144.15K | 12.86K | 12.86K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying BRNX stock.
For fiscal year 2025, BrenX Ltd. (BRNX) reported total revenue of $0.4M.
BrenX Ltd. (BRNX) reported a net loss of $13.9M for the fiscal year ending 2025.
BrenX Ltd. (BRNX) reported an operating income of $-12.7M, resulting in an operating profit margin of -3291.5%. This margin reflects the operational efficiency of the business before interest and taxes.
BrenX Ltd. (BRNX) generated $-3.2M in gross profit for the year, representing a gross profit margin of -829.2%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Persistent operating losses and negative gross profit
Revenue Base Too Thin to Assess Growth
Based on the reported quarterly figures, BRNX posted revenue of $193.5K in 2025 Q1 and Q2 against just $20.5K in 2023 Q3 and Q4, with no revenue reported in the most recent quarters.
The reported revenue series is so small and irregular that growth rates are not meaningful, and the absence of revenue in several recent quarters suggests the commercial model may not yet be generating repeatable sales. The apparent step-up in 2025 Q1 and Q2 is a single data point rather than an established trend. Investors should monitor whether revenue becomes recurring before attributing any durability to the top line.
Cost of Sales Exceeds Revenue Consistently
Reported cost of goods sold of $927.5K against revenue of $193.5K in 2025 Q1 and Q2 implies a gross margin of -3.8%, indicating the company is selling below its direct production cost.
Negative gross profit in every reported period, including -$870.5K in the latest quarters where revenue is unreported, points to unit economics that do not yet cover direct costs. This pattern is typical of early-stage manufacturing scale-up but suggests pricing power is absent at present. Gross margin improvement would need to come from either volume-driven cost absorption or a materially different cost base.
Fixed Overhead Dominates Operating Loss
Quarterly R&D of roughly $774K to $1.2M and SG&A of $1.3M to $1.5M together exceed $2M per quarter, which accounts for most of the reported operating loss of $2.3M to $3.3M.
Operating expenses are largely fixed and do not scale down with the revenue base, so the cost structure is dominated by overhead rather than production. Stock-based compensation of $186K to $457K per quarter also constitutes a meaningful share of spending that does not consume cash. Management's discipline is difficult to judge without a clear decline in these lines relative to revenue.
Share Count Dilution Distorts Per-Share Losses
Reported diluted EPS swings from -$8.05 to -$74.08 across quarters while net income ranges from -$790.5K to -$3.7M, suggesting share count changes or reverse splits are inflating per-share volatility.
The magnitude of EPS movement is disproportionate to the change in net loss, which warrants investigation into the underlying share count and any corporate actions affecting comparability. Negative EPS growth of -4.7% to -7.3% alongside wider loss figures indicates the per-share metric is not a reliable gauge of progress here. Analysts should reconcile reported EPS against net income and share data before relying on it.
Persistent Losses Without Demonstrated Path
Every reported quarter shows an operating loss between $2.3M and $3.3M and negative gross profit, with no quarter in the dataset showing a sign of profitability or breakeven.
The bear case centers on the absence of any period in which gross profit turned positive, which would suggest the business model may require scale or pricing changes that are not visible in these figures. Net margins as low as -112.1% against negligible revenue imply the company depends on external capital to fund operations, though the supplied data does not disclose financing terms. Investors should treat the income statement as showing no demonstrated path to profitability until gross margin turns positive.